FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Juliana McElrath

Research Profile

Living Beings

HIV-1

Chemicals & Drugs

Disorders

HIV Infections

Anatomy

Concepts & Ideas

Procedures

Double-Blind Method

Co-author Network

Publications

TOP 3
Wendy G Tan; Erin E West; Andreas Wieland; Michael J Zilliox; Dan H Barouch; Hyun-Tak Jin; M Juliana McElrath; Pablo Penaloza-MacMaster; Rafi Ahmed
Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors.
Arjun Rustagi; M Juliana McElrath; Brian P Doehle; Michael Gale
Two new monoclonal antibodies for biochemical and flow cytometric analyses of human interferon regulatory factor-3 activation, turnover, and depletion.
Dan H Barouch; Ann Cheung; Amy Chung; Raphael Dolin; Anne-Sophie Dugast; Nicole Frahm; Jaap Goudsmit; M Justin Iampietro; Jinyan Liu; M Juliana McElrath; Maria G Pau; Lauren Peter; Ulf Reimer; Michael S Seaman; Stephen R Walsh; Mo Weijtens; Holger Wenschuh; Peter Abbink; Galit Alter; Lindsey R Baden
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Juliana McElrath (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Wendy G Tan; Erin E West; Andreas Wieland; Michael J Zilliox; Dan H Barouch; Hyun-Tak Jin; M Juliana McElrath; Pablo Penaloza-MacMaster; Rafi Ahmed
Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors.
Journal of virology 2013;87(3):1359-72.
2013: Arjun Rustagi; M Juliana McElrath; Brian P Doehle; Michael Gale
Two new monoclonal antibodies for biochemical and flow cytometric analyses of human interferon regulatory factor-3 activation, turnover, and depletion.
Methods (San Diego, Calif.) 2013;59(2):225-32.
2013: Dan H Barouch; Ann Cheung; Amy Chung; Raphael Dolin; Anne-Sophie Dugast; Nicole Frahm; Jaap Goudsmit; M Justin Iampietro; Jinyan Liu; M Juliana McElrath; Maria G Pau; Lauren Peter; Ulf Reimer; Michael S Seaman; Stephen R Walsh; Mo Weijtens; Holger Wenschuh; Peter Abbink; Galit Alter; Lindsey R Baden
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).
The Journal of infectious diseases 2013;207(2):248-56.
2012: Daniel E Zak; Cecilia A Morgan; Eric R Peterson; Alexander I Salter; Alicia Sato; Devin J Adams; Alan Aderem; Erica Andersen-Nissen; Joleen Borgerding; Joanne T Chang; Stephen C De Rosa; Ann C Duerr; M Kristina Hamilton; Tiffany R Hensley; Akshay T Krishnamurty; M Juliana McElrath
Merck Ad5/HIV induces broad innate immune activation that predicts CD8⁺ T-cell responses but is attenuated by preexisting Ad5 immunity.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(50):E3503-12.
2012: Stephen C De Rosa; Donald K Carter; M Juliana McElrath
OMIP-014: validated multifunctional characterization of antigen-specific human T cells by intracellular cytokine staining.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2012;81(12):1019-21.
2012: Dennis R Burton; Salvatore T Butera; Shane Crotty; Adam Godzik; Daniel E Kaufmann; M Juliana McElrath; Michel C Nussenzweig; Bali Pulendran; Chris N Scanlan; William R Schief; Guido Silvestri; Hendrik Streeck; Bruce D Walker; Laura M Walker; Andrew B Ward; Ian A Wilson; Rafi Ahmed; Dan H Barouch; Richard Wyatt
A Blueprint for HIV Vaccine Discovery.
Cell host & microbe 2012;12(4):396-407.
2012: Romel D Mackelprang; M Juliana McElrath; Edith Nakku-Joloba; Jared M Baeten; Connie Celum; Guy de Bruyn; Deborah Donnell; Max Essex; Carey Farquhar; Jaisri R Lingappa
Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1.
The Journal of infectious diseases 2012;206(8):1299-308.
2012: Olivier D Defawe; Youyi Fong; Nicole Frahm; Erin Gabriel; M Juliana McElrath; Sorachai Nitayaphan; Melissa Pickett; Supachai Rerks-Ngarm; Evgenia Vasilyeva; Donald K Carter; Stephen C De Rosa
Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cells.
Journal of immunological methods 2012;382(1-2):117-28.
2012: M Juliana McElrath; Bruce D Walker
Is an HIV vaccine possible?
Journal of acquired immune deficiency syndromes (1999) 2012;60 Suppl 2():S41-3.
2012: Brian P Doehle; Lamar Fleming; Florian Hladik; M Juliana McElrath; John McNevin; Kristina Chang; Michael Gale
Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells.
Journal of virology 2012;86(16):8499-506.
2012: Brian P Doehle; M Juliana McElrath; John McNevin; Arjun Rustagi; Kristina Chang; Michael Gale
Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism.
Journal of virology 2012;86(16):8367-74.
2012: Tiffany R Hensley; M Juliana McElrath; Stephen C De Rosa; Austin B Easter; Sarah E Gerdts; Antje Heit; Erica Andersen-Nissen
Enumeration of major peripheral blood leukocyte populations for multicenter clinical trials using a whole blood phenotyping assay.
Journal of visualized experiments : JoVE 2012;(67):e4302.
2012: Holly Janes; Esper Kallas; M Juliana McElrath; James I Mullins; Morgane Rolland; Julian Wolfson; Lawrence Corey; Allan DeCamp; Nicole Frahm; David P Friedrich; Erin Gabriel; Paul Goepfert; Tomer Hertz; Peter Gilbert
MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load.
PloS one 2012;7(8):e43396.
2012: Laura Pattacini; Beatriz Perdiguero; Mingchao Shen; Gregory A Spies; Benjamin Wizel; Mariano Esteban; Tayler R Fluharty; Jessica B Graham; Tisha M Graham; Karen Lingnau; M Juliana McElrath; Gregory J Mize; Giuseppe Pantaleo; Jennifer M Lund
A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.
PloS one 2012;7(7):e42163.
2012: Cheng Cheng; Lawrence Corey; Steven C DeRosa; Jason G D Gall; John Hural; M Juliana McElrath; Martha Nason; Richard M Schwartz; Lingshu Wang; LingShu Wang; Susan P Buchbinder; Gary Nabel
Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination.
PloS one 2012;7(4):e33969.
2011: Lamar Ballweber; Michael F Fialkow; Allison Kreger; Gretchen M Lentz; M Juliana McElrath; Barry Robinson; Florian Hladik
Vaginal langerhans cells nonproductively transporting HIV-1 mediate infection of T cells.
Journal of virology 2011;85(24):13443-7.
2011: Lindsey R Baden; Dan H Barouch; William A Blattner; Kara Brandariz; Massimo Cardinali; Olivier D Defawe; Raphael Dolin; Barney S Graham; Yunda Huang; Nidhi Kochar; M Juliana McElrath; Cecilia Morgan; Nina Russell; Magdalena E Sobieszczyk; Georgia D Tomaras
Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects.
The Journal of infectious diseases 2011;204(10):1541-9.
2011: David Friedrich; Warren L Dinges; Yunda Huang; Emilie Jalbert; M Juliana McElrath; Alex Sette; John Sidney; Helen Horton
Vaccine-induced HIV-specific CD8+ T cells utilize preferential HLA alleles and target-specific regions of HIV-1.
Journal of acquired immune deficiency syndromes (1999) 2011;58(3):248-52.
2011: Stephen C De Rosa; Allan deCamp; Barney S Graham; Yunda Huang; Spyros A Kalams; Chuen-Yen Lau; M Juliana McElrath; Cecilia Morgan; Gary Nabel; Evan P Thomas; Georgia D Tomaras; Rafi Ahmed; Rama Akondy; John Bui
HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable.
Journal of immunology (Baltimore, Md. : 1950) 2011;187(6):3391-401.
2011: Magdalena E Sobieszczyk; Jairam R Lingappa; M Juliana McElrath
Host genetic polymorphisms associated with innate immune factors and HIV-1.
Current opinion in HIV and AIDS 2011;6(5):427-34.
2011: Shokrollah Elahi; Ann C Collier; Warren L Dinges; David M Koelle; Kerry Laing; Nicholas Lejarcegui; M Juliana McElrath; Helen Horton
Protective HIV-specific CD8+ T cells evade Treg cell suppression.
Nature medicine 2011;17(8):989-95.
2011: Joshua T Herbeck; Yi Liu; Brandon S Maust; M Juliana McElrath; Angela McKay; Sherry McLaughlin; John McNevin; Brian Birditt; Ann C Collier; Wenjie Deng; Kurt Diem; Indira Genowati; Dana Raugi; Morgane Rolland; Stephanie Sorensen; Joanne D Stekler; Julia N Stoddard; Kim Wong; Hong Zhao; James I Mullins
Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes.
Journal of virology 2011;85(15):7523-34.
2011: Jeffrey S Pufnock; Lisa S Rolczynski; Mathias Wolfl; Erica Andersen-Nissen; Melinda Cigal; M Juliana McElrath; Philip D Greenberg
Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28.
Blood 2011;117(24):6542-51.
2011: Natalie N Zheng; Stephen C De Rosa; Geoffrey S Gottlieb; Stephen E Hawes; M Juliana McElrath; Andrew Mesher; Papa Salif Sow; Joshua Stern; Nancy B Kiviat
Association between peripheral γδ T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa.
Journal of acquired immune deficiency syndromes (1999) 2011;57(2):92-100.
2011: Paul Spearman; Michelle A Lally; Marnie Elizaga; David Montefiori; Georgia D Tomaras; M Juliana McElrath; John Hural; Stephen C De Rosa; Alicia Sato; Yunda Huang; Sharon E Frey; Paul Sato; John Donnelly; Susan Barnett; Lawrence J Corey
A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers.
The Journal of infectious diseases 2011;203(8):1165-73.
2011: Jacques Fellay; Nicole Frahm; Kevin V Shianna; Elizabeth T Cirulli; Danilo R Casimiro; Michael N Robertson; Barton F Haynes; Daniel E Geraghty; M Juliana McElrath; David B Goldstein
Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trial.
The Journal of infectious diseases 2011;203(6):773-9.
2011: M Juliana McElrath
Standing guard at the mucosa.
Immunity 2011;34(2):146-8.
2011: Michael C Keefer; Sharon E Frey; Marnie Elizaga; Barbara Metch; Stephen C De Rosa; Paulo F Barroso; Georgia Tomaras; Massimo Cardinali; Paul A Goepfert; Artur Kalichman; Valérie Philippon; M Juliana McElrath; Xia Jin; Guido Ferrari; Olivier D Defawe; Gail P Mazzara; David Montefiori; Michael Pensiero; Dennis L Panicali; Lawrence Corey
A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects.
Vaccine 2011;29(10):1948-58.
2011: Stephen A Migueles; Julia E Rood; Amy M Berkley; Tiffany Guo; Daniel Mendoza; Andy Patamawenu; Claire W Hallahan; Nancy A Cogliano; Nicole Frahm; Ann Duerr; M Juliana McElrath; Mark Connors
Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.
PLoS pathogens 2011;7(2):e1002002.
2011: Marcel E Curlin; Farah Cassis-Ghavami; Amalia S Magaret; Gregory A Spies; Ann Duerr; Connie Celum; Jorge L Sanchez; Joseph B Margolick; Roger Detels; M Juliana McElrath; Lawrence Corey
Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study.
AIDS (London, England) 2011;25(2):153-8.
2011: Jaisri R Lingappa; M Juliana McElrath; James I Mullins; Edith Nakku-Joloba; Slave Petrovski; Kevin Shianna; Katherine K Thomas; Anna Wald; Jared M Baeten; Connie Celum; Guy de Bruyn; Deborah Donnell; Max Essex; Carey Farquhar; Jacques Fellay; David Goldstein; Bart Haynes; Erin Kahle; James N Kiarie
Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.
PloS one 2011;6(12):e28632.
2011: Beryl A Koblin; Chuen-Yen Lau; M Juliana McElrath; David C Montefiori; Cecilia Morgan; Li Qin; Lilian Saavedra; Georgia D Tomaras; Zhixue Maggie Wang; Lindsey Baden; Martin Casapía; Olivier D Defawe; Paul Goepfert; Barney S Graham
Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial.
PloS one 2011;6(9):e24517.
2011: Gavin J Churchyard; Lawrence Corey; Stephen C De Rosa; Olivier Defawe; Raphael Dolin; J Peter Figueroa; Paul Goepfert; Barney S Graham; Glenda Gray; Doug Grove; John Hural; Spyros Kalams; Artur Kalichman; Michael C Keefer; Michelle Lally; M Juliana McElrath; David C Montefiori; Zoe Moodie; Cecilia Morgan; Gary Nabel; Jean Pape; Mauro Schechter; Georgia D Tomaras; Elizabeth Adams; Lindsey R Baden; Linda-Gail Bekker; William A Blattner
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204).
PloS one 2011;6(8):e21225.
2011: Fusheng Li; M Juliana McElrath; John W Shiver; James Szinger; Danilo R Casimiro; Suzanne Cole; Lawrence Corey; Sheri A Dubey; Adam C Finnefrock; Bette T Korber; Steven G Self
Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study.
PloS one 2011;6(6):e20479.
2011: Samuel O Pine; James G Kublin; Scott M Hammer; Joleen Borgerding; Yunda Huang; Danilo R Casimiro; M Juliana McElrath
Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans.
PloS one 2011;6(4):e18526.
2011: Yi Liu; John P McNevin; Sarah Holte; M Juliana McElrath; James I Mullins
Dynamics of viral evolution and CTL responses in HIV-1 infection.
PloS one 2011;6(1):e15639.
2010: M Juliana McElrath; Barton F Haynes
Induction of immunity to human immunodeficiency virus type-1 by vaccination.
Immunity 2010;33(4):542-54.
2010: M Juliana McElrath
Immune responses to HIV vaccines and potential impact on control of acute HIV-1 infection.
The Journal of infectious diseases 2010;202 Suppl 2():S323-6.
2010: Beth K Thielen; John P McNevin; M Juliana McElrath; Brook Vander Stoep Hunt; Kevin C Klein; Jaisri R Lingappa
Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms.
The Journal of biological chemistry 2010;285(36):27753-66.
2010: Warren L Dinges; Julia Richardt; David Friedrich; Emilie Jalbert; Yi Liu; Claire E Stevens; Janine Maenza; Ann C Collier; Daniel E Geraghty; Jeremy Smith; Zoe Moodie; James I Mullins; M Juliana McElrath; Helen Horton
Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype.
Journal of virology 2010;84(9):4461-8.
2010: Lawrence Corey; M Juliana McElrath
HIV vaccines: mosaic approach to virus diversity.
Nature medicine 2010;16(3):268-70.
2010: M Juliana McElrath; Lamar Ballweber; Andrew Terker; Allison Kreger; Polachai Sakchalathorn; Barry Robinson; Michael F Fialkow; Gretchen M Lentz; Florian Hladik
Ex vivo comparison of microbicide efficacies for preventing HIV-1 genomic integration in intraepithelial vaginal cells.
Antimicrobial agents and chemotherapy 2010;54(2):763-72.
2010: Dilbinder K Gill; Yunda Huang; Gail L Levine; Anna Sambor; Donald K Carter; Alicia Sato; Jakub Kopycinski; Peter Hayes; Bridget Hahn; Josephine Birungi; Tony Tarragona-Fiol; Hong Wan; Mark Randles; Andrew Raxworthy Cooper; Aloysius Ssemaganda; Lorna Clark; Pontiano Kaleebu; Steven G Self; Richard Koup; Blake Wood; M Juliana McElrath; Josephine H Cox; John Hural; Jill Gilmour
Equivalence of ELISpot assays demonstrated between major HIV network laboratories.
PloS one 2010;5(12):e14330.
2010: Michael Vaine; Shixia Wang; Qin Liu; James Arthos; David Montefiori; Paul Goepfert; M Juliana McElrath; Shan Lu
Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.
PloS one 2010;5(11):e13916.
2010: Laurence Peiperl; Cecilia Morgan; Zoe Moodie; Hongli Li; Nina Russell; Barney S Graham; Georgia D Tomaras; Stephen C De Rosa; M Juliana McElrath
Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054).
PloS one 2010;5(10):e13579.
2010: Barney S Graham; M Juliana McElrath; Michael C Keefer; Kyle Rybczyk; David Berger; Kent J Weinhold; Janet Ottinger; Guido Ferarri; David C Montefiori; Don Stablein; Carol Smith; Richard Ginsberg; John Eldridge; Ann Duerr; Patricia Fast; Barton F Haynes
Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity.
PloS one 2010;5(8):e11995.
2010: Annelie Tjernlund; Jia Zhu; Kerry Laing; Kurt Diem; David McDonald; Julio Vazquez; Jianhong Cao; Claes Ohlen; M Juliana McElrath; Louis J Picker; Lawrence Corey
In situ detection of Gag-specific CD8+ cells in the GI tract of SIV infected Rhesus macaques.
Retrovirology 2010;7():12.
2010: Cheng Cheng; Jason G D Gall; Martha Nason; C Richter King; Richard A Koup; Mario Roederer; M Juliana McElrath; Cecilia A Morgan; Gavin Churchyard; Lindsey R Baden; Ann C Duerr; Michael C Keefer; Barney S Graham; Gary Nabel
Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization.
Journal of virology 2010;84(1):630-8.
2009: Yi Liu; John McNevin; Morgane Rolland; Hong Zhao; Wenjie Deng; Janine Maenza; Claire E Stevens; Ann C Collier; M Juliana McElrath; James I Mullins
Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses.
The Journal of infectious diseases 2009;200(12):1825-33.
2009: Samuel O Pine; M Juliana McElrath; Pierre-Yves Bochud
Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.
AIDS (London, England) 2009;23(18):2387-95.
2009: Uma Malhotra; J Nolin; Helen Horton; Fusheng Li; L Corey; James I Mullins; M Juliana McElrath
Functional properties and epitope characteristics of T-cells recognizing natural HIV-1 variants.
Vaccine 2009;27(48):6678-87.
2009: Yi Liu; Amanda Woodward; Haiying Zhu; Thomas Andrus; John McNevin; Jean Lee; James I Mullins; Lawrence Corey; M Juliana McElrath; Tuofu Zhu
Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners.
Journal of virology 2009;83(20):10821-9.
2009: Brian P Doehle; Florian Hladik; John McNevin; M Juliana McElrath; Michael Gale
Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells.
Journal of virology 2009;83(20):10395-405.
2009: Ryan M Troyer; John McNevin; Yi Liu; Shao Chong Zhang; Randall W Krizan; Awet Abraha; Denis M Tebit; Hong Zhao; Santiago Avila; Michael A Lobritz; M Juliana McElrath; Sylvie Le Gall; James I Mullins; Eric J Arts
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.
PLoS pathogens 2009;5(4):e1000365.
2009: Paul Spearman; Spyros Kalams; Marnie Elizaga; Barbara Metch; Ya-Lin Chiu; Mary Allen; Kent J Weinhold; Guido Ferrari; Scott D Parker; M Juliana McElrath; Sharon E Frey; Jonathan D Fuchs; Michael C Keefer; Michael D Lubeck; Michael Egan; Ralph Braun; John H Eldridge; Barton F Haynes; Lawrence Corey
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.
Vaccine 2009;27(2):243-9.
2009: Lawrence Corey; M Juliana McElrath; James Kublin
Post-step modifications for research on HIV vaccines.
AIDS (London, England) 2009;23(1):3-8.
2008: M Juliana McElrath; Stephen C De Rosa; Zoe Moodie; Sheri Dubey; Lisa Kierstead; Holly Janes; Olivier D Defawe; Donald K Carter; Esper Kallas; Rama Akondy; Susan P Buchbinder; Michael N Robertson; Devan V Mehrotra; Steven G Self; Lawrence Corey; John W Shiver; Danilo R Casimiro
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.
Lancet 2008;372(9653):1894-905.
2008: Susan P Buchbinder; Devan V Mehrotra; Ann Duerr; Daniel W Fitzgerald; Robin Mogg; David Li; Peter B Gilbert; Javier R Lama; Michael Marmor; Carlos del Rio; M Juliana McElrath; Danilo R Casimiro; Keith M Gottesdiener; Jeffrey A Chodakewitz; Esper Kallas; Michael N Robertson
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.
Lancet 2008;372(9653):1881-93.
2008: Emily C Speelmon; Devon Livingston-Rosanoff; anthony desbien; Jean Lee; W David Wick; Florian Hladik; M Juliana McElrath
Impaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals.
AIDS research and human retroviruses 2008;24(11):1415-27.
2008: Nicholas Shulman; Matthew Bellew; George Snelling; Donald Carter; Yunda Huang; Hongli Li; Steven G Self; M Juliana McElrath; Stephen C De Rosa
Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2008;73(9):847-56.
2008: Florian Hladik; M Juliana McElrath
Setting the stage: host invasion by HIV.
Nature reviews. Immunology 2008;8(6):447-57.
2008: Stephen D De Rosa; M Juliana McElrath
T cell responses generated by HIV vaccines in clinical trials.
Current opinion in HIV and AIDS 2008;3(3):375-9.
2008: Jianhong Cao; John McNevin; Matthew D McSweyn; Yi Liu; James I Mullins; M Juliana McElrath
Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistance.
Journal of virology 2008;82(1):495-502.
2007: Li Qin; Peter B Gilbert; Lawrence Corey; M Juliana McElrath; Steven G Self
A framework for assessing immunological correlates of protection in vaccine trials.
The Journal of infectious diseases 2007;196(9):1304-12.
2007: Yi Liu; John McNevin; Hong Zhao; Denis M Tebit; Ryan M Troyer; Matthew D McSweyn; Ananta K Ghosh; Daniel Shriner; Eric J Arts; M Juliana McElrath; James I Mullins
Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape.
Journal of virology 2007;81(22):12179-88.
2007: Natalie N Zheng; M Juliana McElrath; Papa Salif Sow; Stephen E Hawes; Habibatou Diallo-Agne; Joshua E Stern; Fusheng Li; Andrew L Mesher; Akeliah D Robinson; Geoffrey S Gottlieb; Yunda Huang; Nancy B Kiviat
Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
Journal of virology 2007;81(17):9061-71.
2007: Zane Kraft; Nina R Derby; Ruth A McCaffrey; Rachel Niec; Wendy Blay Puryear; Nancy Haigwood; Eirini Moysi; Cheryl J Saunders; Terri Wrin; Christos J Petropoulos; M Juliana McElrath; Leonidas Stamatatos
Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies.
Journal of virology 2007;81(12):6402-11.
2007: Helen Horton; Evan P Thomas; Jason A Stucky; Ian Frank; Zoe Moodie; Yunda Huang; Ya-Lin Chiu; M Juliana McElrath; Stephen C De Rosa
Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination.
Journal of immunological methods 2007;323(1):39-54.
2007: Uma Malhotra; Fusheng Li; Jessica Nolin; Megan Allison; Hong Zhao; James I Mullins; Steven G Self; M Juliana McElrath
Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection.
Journal of virology 2007;81(10):5225-37.
2007: Marta Bull; Deborah Lee; Jason Stucky; Ya-Lin Chiu; Abbe Rubin; Helen Horton; M Juliana McElrath
Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials.
Journal of immunological methods 2007;322(1-2):57-69.
2007: Florian Hladik; Polachai Sakchalathorn; Lamar Ballweber; Gretchen M Lentz; Michael F Fialkow; David A Eschenbach; M Juliana McElrath
Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1.
Immunity 2007;26(2):257-70.
2007: Nina D Russell; Barney S Graham; Michael C Keefer; M Juliana McElrath; Steven G Self; Kent J Weinhold; David C Montefiori; Guido Ferrari; Helen Horton; Georgia D Tomaras; Sanjay Gurunathan; Lynn Baglyos; Sharon E Frey; Mark MULLIGAN; Clayton D Harro; Susan P Buchbinder; Lindsey R Baden; William A Blattner; Beryl A Koblin; Lawrence Corey
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):203-12.
2007: Paul A Goepfert; Georgia D Tomaras; Helen Horton; David Montefiori; Guido Ferrari; Mark Deers; Gerald Voss; Marguerite Koutsoukos; Louise Pedneault; Pierre Vandepapeliere; M Juliana McElrath; Paul Spearman; Jonathan D Fuchs; Beryl A Koblin; William A Blattner; Sharon Frey; Lindsey R Baden; Clayton D Harro; Thomas Evans
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.
Vaccine 2007;25(3):510-8.
2007: Uma Malhotra; Jessica Nolin; James I Mullins; M Juliana McElrath
Comprehensive epitope analysis of cross-clade Gag-specific T-cell responses in individuals with early HIV-1 infection in the US epidemic.
Vaccine 2007;25(2):381-90.
2006: Helen Horton; Ian Frank; Ruth Baydo; Emilie Jalbert; Justin Penn; Sean Wilson; John McNevin; Matthew D McSweyn; Deborah Lee; Yunda Huang; Stephen C De Rosa; M Juliana McElrath
Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(10):7406-15.
2006: Helen Horton; Colin Havenar-Daughton; Deborah Lee; Erin Moore; Jianhong Cao; John McNevin; Thomas Andrus; Haiying Zhu; Abbe Rubin; Tuofu Zhu; Connie Celum; M Juliana McElrath
Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection.
Journal of virology 2006;80(19):9779-88.
2006: Yi Liu; John McNevin; Jianhong Cao; Hong Zhao; Indira Genowati; Kim Wong; Sherry McLaughlin; Matthew D McSweyn; Kurt Diem; Claire E Stevens; Janine Maenza; Hongxia He; David C Nickle; Daniel Shriner; Sarah Holte; Ann C Collier; Lawrence Corey; M Juliana McElrath; James I Mullins
Selection on the human immunodeficiency virus type 1 proteome following primary infection.
Journal of virology 2006;80(19):9519-29.
2006: Joanne Stekler; Janine Maenza; Claire Stevens; Sarah Holte; Uma Malhotra; M Juliana McElrath; Lawrence Corey; Ann C Collier
Abacavir hypersensitivity reaction in primary HIV infection.
AIDS (London, England) 2006;20(9):1269-74.
2006: Uma Malhotra; Claire Huntsberry; Sarah Holte; Jean Lee; Lawrence Corey; M Juliana McElrath
CD4+ T cell receptor repertoire perturbations in HIV-1 infection: association with plasma viremia and disease progression.
Clinical immunology (Orlando, Fla.) 2006;119(1):95-102.
2006: Emily C Speelmon; Devon Livingston-Rosanoff; Shuying Sue Li; Quyen Vu; John Bui; Daniel E Geraghty; Lue Ping Zhao; M Juliana McElrath
Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection.
Journal of virology 2006;80(5):2463-71.
2006: Huanliang Liu; Mary Carrington; Chunhui Wang; Sarah Holte; Jean Lee; Benjamin Greene; Florian Hladik; David M Koelle; Anna Wald; Kyoko Kurosawa; Charles Rinaldo; Connie Celum; Roger Detels; Lawrence Corey; M Juliana McElrath; Tuofu Zhu
Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility.
The Journal of infectious diseases 2006;193(5):698-702.
2005: Paul A Goepfert; Helen Horton; M Juliana McElrath; Sanjay Gurunathan; Guido Ferrari; Georgia D Tomaras; David C Montefiori; Mary Allen; Ya-Lin Chiu; Paul Spearman; Jonathan D Fuchs; Beryl A Koblin; William A Blattner; Sharon Frey; Michael C Keefer; Lindsey R Baden; Lawrence Corey
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects.
The Journal of infectious diseases 2005;192(7):1249-59.
2005: Florian Hladik; Huanliang Liu; Emily C Speelmon; Devon Livingston-Rosanoff; Sean Wilson; Polachai Sakchalathorn; Yon Hwangbo; Benjamin Greene; Tuofu Zhu; M Juliana McElrath
Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.
Journal of virology 2005;79(18):11677-84.
2005: Huanliang Liu; Florian Hladik; Thomas Andrus; Polachai Sakchalathorn; Gretchen M Lentz; Michael F Fialkow; Lawrence Corey; M Juliana McElrath; Tuofu Zhu
Most DC-SIGNR transcripts at mucosal HIV transmission sites are alternatively spliced isoforms.
European journal of human genetics : EJHG 2005;13(6):707-15.
2004: N N Zheng; Nancy B Kiviat; Papa Salif Sow; Stephen E Hawes; A Wilson; H Diallo-Agne; Cathy W Critchlow; Geoffrey S Gottlieb; Luwy Musey; M Juliana McElrath
Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.
Journal of virology 2004;78(24):13934-42.
2004: David C Montefiori; Barbara Metch; M Juliana McElrath; Steven G Self; Kent J Weinhold; Lawrence Corey
Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines.
The Journal of infectious diseases 2004;190(11):1962-9.
2004: Helen Horton; Nina Russell; Erin Moore; Ian Frank; Ruth Baydo; Colin Havenar-Daughton; Deborah Lee; Mark Deers; Michael G Hudgens; Kent J Weinhold; M Juliana McElrath
Correlation between interferon- gamma secretion and cytotoxicity, in virus-specific memory T cells.
The Journal of infectious diseases 2004;190(9):1692-6.
2004: Huanliang Liu; Yon Hwangbo; Sarah Holte; Jean Lee; Chunhui Wang; Nicole Kaupp; Haiying Zhu; Connie Celum; Lawrence Corey; M Juliana McElrath; Tuofu Zhu
Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1.
The Journal of infectious diseases 2004;190(6):1055-8.
2004: Deborah Lee; Barney S Graham; Ya-Lin Chiu; Peter B Gilbert; M Juliana McElrath; Robert B Belshe; Susan P Buchbinder; Haynes W Sheppard; Beryl A Koblin; Kenneth H Mayer; Michael C Keefer; Mark MULLIGAN; Connie Celum
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160.
The Journal of infectious diseases 2004;190(5):903-7.
2004: Uma Malhotra; Ronald J Bosch; Rui Wang; Ann Collier; M Juliana McElrath
Effect of adjunct hydroxyurea on helper T cell immunity in HIV type 1-infected patients with virological suppression.
AIDS research and human retroviruses 2004;20(8):807-12.
2004: Guido Ferrari; Wesley Neal; Janet Ottinger; Anizsa M Jones; Bradley H Edwards; Paul A Goepfert; Michael R Betts; Richard A Koup; Susan Buchbinder; M Juliana McElrath; Jim Tartaglia; Kent J Weinhold
Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(3):2126-33.
2004: Michael G Hudgens; Steven G Self; Ya-Lin Chiu; Nina D Russell; Helen Horton; M Juliana McElrath
Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials.
Journal of immunological methods 2004;288(1-2):19-34.
2004: Peter F Wright; Jiri Mestecky; M Juliana McElrath; Michael C Keefer; Geoffrey J Gorse; Paul A Goepfert; Zina Moldoveanu; David Schwartz; Paul Spearman; Raphaelle El Habib; Michelle Donna Spring; Yuwei Zhu; Carol Smith; Jorge Flores; Kent J Weinhold
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein.
The Journal of infectious diseases 2004;189(7):1221-31.
2004: Uma Malhotra; Ronald J Bosch; Ellen Chan; Rui Wang; Margaret A Fischl; Ann C Collier; M Juliana McElrath
Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 disease.
The Journal of infectious diseases 2004;189(3):515-9.
2003: Howard M Lederman; Paige L Williams; Julia W Wu; Thomas G Evans; Susan E Cohn; J Allen McCutchan; Susan L Koletar; Richard Hafner; Elizabeth Connick; Fred T Valentine; M Juliana McElrath; Norbert J Roberts; Judith S Currier
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion.
The Journal of infectious diseases 2003;188(12):1794-803.
2003: Ayub Ali; Satish Pillai; Hwee Ng; Rachel Lubong; Douglas D Richman; Beth D Jamieson; Yan Ding; M Juliana McElrath; John C Guatelli; Otto O Yang
Broadly increased sensitivity to cytotoxic T lymphocytes resulting from Nef epitope escape mutations.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(8):3999-4005.
2003: Jianhong Cao; John McNevin; Uma Malhotra; M Juliana McElrath
Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(7):3837-46.
2003: Chihiro Morishima; Luwy Musey; Marnie L Elizaga; Kersten Gaba; Megan Allison; Robert L Carithers; David R Gretch; M Juliana McElrath
Hepatitis C virus-specific cytolytic T cell responses after antiviral therapy.
Clinical immunology (Orlando, Fla.) 2003;108(3):211-20.
2003: Florian Hladik; anthony desbien; Jean Lang; Lei Wang; Yan Ding; Sarah Holte; Aaron Wilson; Younong Xu; Micky Moerbe; Steve Schmechel; M Juliana McElrath
Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(5):2671-83.
2003: Luwy Musey; Yan Ding; Marnie L Elizaga; Richard Ha; Connie Celum; M Juliana McElrath
HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(2):1094-101.
2003: Jianhong Cao; John McNevin; Sarah Holte; Lisa Fink; Lawrence Corey; M Juliana McElrath
Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.
Journal of virology 2003;77(12):6867-78.
2003: Tuofu Zhu; Lawrence Corey; Yon Hwangbo; Jean M Lee; Gerald Learn; James I Mullins; M Juliana McElrath
Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals.
Journal of virology 2003;77(11):6108-16.
2003: Uma Malhotra; Sarah Holte; Tuofu Zhu; Elizabeth Delpit; Claire Huntsberry; Alessandro Sette; Raj Shankarappa; Janine Maenza; Lawrence Corey; M Juliana McElrath
Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection.
Journal of virology 2003;77(4):2663-74.
2003: Nina D Russell; Michael G Hudgens; Richard Ha; Colin Havenar-Daughton; M Juliana McElrath
Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity.
The Journal of infectious diseases 2003;187(2):226-42.
2003: Luwy Musey; Y Ding; Jianhong Cao; J Lee; C Galloway; A Yuen; Keith R Jerome; M Juliana McElrath
Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes.
Journal of virology 2003;77(1):291-300.
2002: Marnie L Elizaga; M Juliana McElrath
Progress in the development of a preventive HIV-1 vaccine.
Clinics in laboratory medicine 2002;22(4):963-80, vii.
2002: Kalpana Gupta; Michael G Hudgens; Lawrence Corey; M Juliana McElrath; Kent J Weinhold; David C Montefiori; Geoffrey J Gorse; Sharon E Frey; Michael C Keefer; Thomas G Evans; Raphael Dolin; David H Schwartz; Clayton D Harro; Barney Graham; Paul Spearman; Mark MULLIGAN; Paul A Goepfert
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A.
Journal of acquired immune deficiency syndromes (1999) 2002;29(3):254-61.
2001: Guido Ferrari; W Neal; A Jones; N Olender; Janet Ottinger; Richard Ha; M Juliana McElrath; Paul A Goepfert; Kent J Weinhold
CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition.
Immunology letters 2001;79(1-2):37-45.
2001: Steve Schmechel; N Russell; Florian Hladik; J Lang; A Wilson; Richard Ha; anthony desbien; M Juliana McElrath
Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons.
Immunology letters 2001;79(1-2):21-7.
2001: Hillary D White; Luwy Musey; M M Andrews; Grant R Yeaman; L R DeMars; Paul Manganiello; Alexandra L Howell; Charles R Wira; William R Green; M Juliana McElrath
Human immunodeficiency virus-specific and CD3-redirected cytotoxic T lymphocyte activity in the human female reproductive tract: lack of correlation between mucosa and peripheral blood.
The Journal of infectious diseases 2001;183(6):977-83.
2001: Florian Hladik; S Bender; RE Akridge; Y X Hu; C Galloway; D Francis; M Juliana McElrath
Recombinant HIV-1 glycoprotein 120 induces distinct types of delayed hypersensitivity in persons with or without pre-existing immunologic memory.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(5):3580-8.
2001: A Seth; J Markee; A Hoering; A Sevin; D E Sabath; Joern schmitz; Marcelo J Kuroda; Michelle A Lifton; M S Hirsch; A C Collier; Norman L Letvin; M Juliana McElrath
Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy.
The Journal of infectious diseases 2001;183(5):722-9.
2001: Thomas G Evans; M Juliana McElrath; T Matthews; David Montefiori; Kent J Weinhold; Mark Wolff; Michael C Keefer; Esper Kallas; Lawrence Corey; Geoffrey J Gorse; Robert B Belshe; Barney S Graham; Paul Spearman; David H Schwartz; Mark MULLIGAN; Paul A Goepfert; Patricia Fast; Phillip W. Berman; M Powell; D Francis
QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans.
Vaccine 2001;19(15-16):2080-91.
2001: Uma Malhotra; Sarah Holte; S Dutta; M Michelle Berrey; Elizabeth Delpit; David M Koelle; A Sette; Lawrence Corey; M Juliana McElrath
Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment.
The Journal of clinical investigation 2001;107(4):505-17.
2000: Robert T Schooley; C Spino; Daniel R Kuritzkes; B D Walker; F A Valentine; Martin S Hirsch; E Cooney; G Friedland; S Kundu; Thomas C Merigan; M Juliana McElrath; Avanta Collier; S Plaeger; Ronald T Mitsuyasu; J Kahn; P Haslett; P Uherova; Victor DeGruttola; S Chiu; B Zhang; G Jones; Dawn Bell; N Ketter; T Twadell; D Chernoff; ME Rosandich
Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214.
The Journal of infectious diseases 2000;182(5):1357-64.
2000: M Juliana McElrath; Lawrence Corey; David Montefiori; Mark Wolff; David H Schwartz; Michael C Keefer; Robert B Belshe; Barney S Graham; T Matthews; P Wright; Geoffrey J Gorse; Raphael Dolin; Phillip W. Berman; D Francis; AM Duliege; Dani P Bolognesi; Donald Stablein; N Ketter; Patricia Fast
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group.
AIDS research and human retroviruses 2000;16(9):907-19.
2000: Uma Malhotra; M Michelle Berrey; Y Huang; J Markee; D J Brown; S Ap; Luwy Musey; Timothy W Schacker; Lawrence Corey; M Juliana McElrath
Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 2000;181(1):121-31.
1999: Peter F Wright; John S Lambert; Geoffrey J Gorse; RH Hsieh; M Juliana McElrath; Kent J Weinhold; Diane Wara; Edwin L Anderson; Michael C Keefer; S Jackson; LJ Wagner; D P Francis; Patricia Fast; James McNamara
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women.
The Journal of infectious diseases 1999;180(4):1080-8.
1999: Florian Hladik; Gretchen M Lentz; Elizabeth Delpit; A McElroy; M Juliana McElrath
Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR5+ Th1 phenotype.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(4):2306-13.
1999: Thomas G Evans; Michael C Keefer; Kent J Weinhold; Mark Wolff; David Montefiori; Geoffrey J Gorse; Barney S Graham; M Juliana McElrath; Mary Lou Clements-Mann; Mark MULLIGAN; Patricia Fast; MC Walker; Jean-Louis Excler; AM Duliege; Jim Tartaglia
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.
The Journal of infectious diseases 1999;180(2):290-8.
1999: Luwy Musey; John N Krieger; James P Hughes; Timothy W Schacker; Lawrence Corey; M Juliana McElrath
Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection.
The Journal of infectious diseases 1999;180(2):278-84.
1999: Florian Hladik; Gretchen M Lentz; RE Akridge; G Peterson; H Kelley; A McElroy; M Juliana McElrath
Dendritic cell-T-cell interactions support coreceptor-independent human immunodeficiency virus type 1 transmission in the human genital tract.
Journal of virology 1999;73(7):5833-42.
1999: RE Akridge; Florian Hladik; J Markee; C Alef; H Kelley; A Collier; A Collier; M Juliana McElrath
Cellular immunity and target cell susceptibility in persons with repeated HIV-1 exposure.
Immunology letters 1999;66(1-3):15-9.
1999: Wei Chun Goh; J Markee; RE Akridge; M Meldorf; Luwy Musey; T Karchmer; M Krone; A Collier; Lawrence Corey; Michael Emerman; M Juliana McElrath
Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects.
The Journal of infectious diseases 1999;179(3):548-57.
1999: Geoffrey J Gorse; Lawrence Corey; Gira B Patel; Mahendra D Mandava; RH Hsieh; TJ Matthews; MC Walker; M Juliana McElrath; Phillip W. Berman; M M Eibl; Robert B Belshe
HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
AIDS research and human retroviruses 1999;15(2):115-32.
1998: amy sheon; L Wagner; M Juliana McElrath; Michael C Keefer; E Zimmerman; H Israel; D Berger; Patricia Fast
Preventing discrimination against volunteers in prophylactic HIV vaccine trials: lessons from a phase II trial.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(5):519-26.
1998: Donald P Francis; TJ Gregory; M Juliana McElrath; Robert B Belshe; Geoffrey J Gorse; Sricharoen Migasena; Dwip Kitayaporn; P Pitisuttitham; T Matthews; David H Schwartz; Phillip W. Berman
Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.
AIDS research and human retroviruses 1998;14 Suppl 3():S325-31.
1998: Mary Lou Clements-Mann; Kent J Weinhold; TJ Matthews; Barney S Graham; Geoffrey J Gorse; Michael C Keefer; M Juliana McElrath; RH Hsieh; Jiri Mestecky; Susan Zolla-Pazner; J Mascola; David H Schwartz; Robert Siliciano; Lawrence Corey; Peter F Wright; Robert B Belshe; Raphael Dolin; S Jackson; S Xu; Patricia Fast; MC Walker; Donald Stablein; Jean-Louis Excler; Jim Tartaglia; E Paoletti
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group.
The Journal of infectious diseases 1998;177(5):1230-46.
1998: Geoffrey J Gorse; M Juliana McElrath; TJ Matthews; RH Hsieh; Robert B Belshe; Lawrence Corey; Sharon E Frey; Donald J Kennedy; MC Walker; M M Eibl
Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
Vaccine 1998;16(5):493-506.
1998: Barney S Graham; M Juliana McElrath; Ruth I Connor; David H Schwartz; Geoffrey J Gorse; Michael C Keefer; Mark MULLIGAN; TJ Matthews; Steven Wolinsky; David C Montefiori; Sten Vermund; John S Lambert; Lawrence Corey; Robert B Belshe; Raphael Dolin; Peter F Wright; Bette T Korber; M C Wolff; Patricia Fast
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group.
The Journal of infectious diseases 1998;177(2):310-9.
1998: Lawrence Corey; M Juliana McElrath; Kent J Weinhold; T Matthews; Donald Stablein; B Graham; Michael C Keefer; David H Schwartz; Geoffrey J Gorse
Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group.
The Journal of infectious diseases 1998;177(2):301-9.
1997: Luwy Musey; J Hughes; Timothy W Schacker; Theresa Shea; Lawrence Corey; M Juliana McElrath
Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
The New England journal of medicine 1997;337(18):1267-74.
1997: Michael C Keefer; Mark Wolff; Geoffrey J Gorse; Barney S Graham; Lawrence Corey; Mary Lou Clements-Mann; N Verani-Ketter; S Erb; C M Smith; Robert B Belshe; LJ Wagner; M Juliana McElrath; David H Schwartz; Patricia Fast
Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group.
AIDS research and human retroviruses 1997;13(14):1163-77.
1997: Shan-Lu Liu; Timothy W Schacker; Luwy Musey; Daniel Shriner; M Juliana McElrath; Lawrence Corey; James I Mullins
Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses.
Journal of virology 1997;71(6):4284-95.
1997: Susan Zolla-Pazner; C Alving; Robert B Belshe; Phillip W. Berman; Sherri Burda; P Chigurupati; M L Clements; AM Duliege; Jean-Louis Excler; Catarina E Hioe; J Kahn; M Juliana McElrath; S Sharpe; F Sinangil; K Steimer; MC Walker; N Wassef; S Xu
Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines.
The Journal of infectious diseases 1997;175(4):764-74.
1997: Guido Ferrari; W Humphrey; M Juliana McElrath; Jean-Louis Excler; AM Duliege; M L Clements; Lawrence Corey; Dani P Bolognesi; Kent J Weinhold
Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(4):1396-401.
1997: M Juliana McElrath; Robert Siliciano; Kent J Weinhold
HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization, and quantitation.
AIDS research and human retroviruses 1997;13(3):211-6.
1997: W B Paxton; Robert W Coombs; M Juliana McElrath; Michael C Keefer; J Hughes; F Sinangil; D Chernoff; Lisa M Demeter; B Williams; Lawrence Corey
Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
The Journal of infectious diseases 1997;175(2):247-54.
1997: Luwy Musey; Y Hu; Linda O Eckert; M Christensen; T Karchmer; M Juliana McElrath
HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women.
The Journal of experimental medicine 1997;185(2):293-303.
1997: S J Kent; Philip D Greenberg; M C Hoffman; RE Akridge; M Juliana McElrath
Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(2):807-15.
1996: Barney S Graham; Michael C Keefer; M Juliana McElrath; Geoffrey J Gorse; David H Schwartz; Kent J Weinhold; TJ Matthews; J R Esterlitz; F Sinangil; Patricia Fast
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group.
Annals of internal medicine 1996;125(4):270-9.
1996: Michael C Keefer; Barney S Graham; M Juliana McElrath; TJ Matthews; Donald Stablein; Lawrence Corey; Peter F Wright; D Lawrence; Patricia Fast; Kent J Weinhold; RH Hsieh; David Chernoff; C Dekker; Raphael Dolin
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group.
AIDS research and human retroviruses 1996;12(8):683-93.
1996: M Juliana McElrath; Lawrence Corey; Philip D Greenberg; T J Matthews; David C Montefiori; Lee Rowen; Leroy Hood; James I Mullins
Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(9):3972-7.
1996: John R Mascola; Stuart Snyder; O S Weislow; S M Belay; Robert B Belshe; David H Schwartz; M L Clements; Raphael Dolin; Barney S Graham; Geoffrey J Gorse; Michael C Keefer; M Juliana McElrath; MC Walker; K F Wagner; John G McNeil; Francine E McCutchan; Donald S. Burke
Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
The Journal of infectious diseases 1996;173(2):340-8.
1995: S J Kent; Lawrence Corey; Michael B Agy; William R Morton; M Juliana McElrath; Philip D Greenberg
Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina.
The Journal of clinical investigation 1995;95(1):248-56.
1994: Michael C Keefer; Barney S Graham; Robert B Belshe; David H Schwartz; Lawrence Corey; Dani P Bolognesi; Donald Stablein; D C Montefiori; M Juliana McElrath; M L Clements
Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.
AIDS research and human retroviruses 1994;10(12):1713-23.
1994: Barney S Graham; Geoffrey J Gorse; David H Schwartz; Michael C Keefer; M Juliana McElrath; TJ Matthews; Peter F Wright; Robert B Belshe; M L Clements; Raphael Dolin
Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network.
The Journal of infectious diseases 1994;170(4):782-6.
1994: M Juliana McElrath; M Rabin; M Hoffman; S Klucking; Jose Garcia-Martinez; Philip D Greenberg
Evaluation of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses utilizing B-lymphoblastoid cell lines transduced with the CD4 gene and infected with HIV-1.
Journal of virology 1994;68(8):5074-83.
1994: M Juliana McElrath; M Hoffman; S Kluckling; Lawrence Corey; Philip D Greenberg
HIV-infected macrophages as efficient stimulator cells for detection of cytotoxic T cell responses to HIV in seronegative and seropositive vaccine recipients.
AIDS research and human retroviruses 1994;10(5):541-9.
1994: M Juliana McElrath; Lawrence Corey; D Berger; M C Hoffman; S Klucking; Joan Dragavon; E Peterson; Philip D Greenberg
Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting.
The Journal of infectious diseases 1994;169(1):41-7.
1994: M Juliana McElrath; Lawrence Corey; Philip D Greenberg
Evaluation of cytotoxic T cell responses to candidate HIV-1 vaccines in HIV-1-uninfected individuals.
AIDS research and human retroviruses 1994;10 Suppl 2():S69-72.
1993: E L Cooney; M Juliana McElrath; Lawrence Corey; Shiu-Lok Hu; Ann C Collier; Douglas E (Doug) Arditti; M Hoffman; Robert W Coombs; G E Smith; Philip D Greenberg
Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(5):1882-6.